Cargando…
Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4
Lambertianic acid (LA) is a biologically active compound from the leaves of Pinus koraiensis. In the present study, apoptotic mechanisms of LA plus TNF-related apoptosis-inducing ligand (TRAIL) were elucidated in non-small cell lung cancer cells (NSCLCs). Cytotoxicity assay, flow cytometry, immunopr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983579/ https://www.ncbi.nlm.nih.gov/pubmed/29772677 http://dx.doi.org/10.3390/ijms19051476 |
_version_ | 1783328449829535744 |
---|---|
author | Ahn, Deok Soo Lee, Hyo Jung Hwang, Jisung Han, Hyukgyu Kim, Bonglee Shim, BumSang Kim, Sung-Hoon |
author_facet | Ahn, Deok Soo Lee, Hyo Jung Hwang, Jisung Han, Hyukgyu Kim, Bonglee Shim, BumSang Kim, Sung-Hoon |
author_sort | Ahn, Deok Soo |
collection | PubMed |
description | Lambertianic acid (LA) is a biologically active compound from the leaves of Pinus koraiensis. In the present study, apoptotic mechanisms of LA plus TNF-related apoptosis-inducing ligand (TRAIL) were elucidated in non-small cell lung cancer cells (NSCLCs). Cytotoxicity assay, flow cytometry, immunoprecipitation, and Western blotting were performed. Here, combined treatment of LA and TRAIL increased cytotoxicity, sub-G1 population, cleaved poly (ADP-ribose) polymerase (PARP), and caspase3/8/9 in A549 and H1299 cells compared to LA or TRAIL alone. Furthermore, combined treatment of LA and TRAIL significantly decreased antiapoptotic proteins such as B-cell lymphoma 2 (Bcl-2), Fas-like inhibitor protein (FLIP), and X-linked inhibitor of apoptosis protein (XIAP), and enhanced the activation of proapoptotic proteins Bid compared to LA or TRAIL alone. In addition, combined treatment of LA and TRAIL upregulated the expression of Death receptor 4 (DR4) and downregulated phosphorylation of nuclear factor κ-light-chain-enhancer of activated B cells (p-NF-κB), inhibitory protein of kB family (p-IκB), and FLIP in A549 and H1299 cells along with disrupted binding of XIAP with caspase3 or NF-κB. Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-κB in TRAIL resistant NSCLCs. |
format | Online Article Text |
id | pubmed-5983579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59835792018-06-05 Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 Ahn, Deok Soo Lee, Hyo Jung Hwang, Jisung Han, Hyukgyu Kim, Bonglee Shim, BumSang Kim, Sung-Hoon Int J Mol Sci Article Lambertianic acid (LA) is a biologically active compound from the leaves of Pinus koraiensis. In the present study, apoptotic mechanisms of LA plus TNF-related apoptosis-inducing ligand (TRAIL) were elucidated in non-small cell lung cancer cells (NSCLCs). Cytotoxicity assay, flow cytometry, immunoprecipitation, and Western blotting were performed. Here, combined treatment of LA and TRAIL increased cytotoxicity, sub-G1 population, cleaved poly (ADP-ribose) polymerase (PARP), and caspase3/8/9 in A549 and H1299 cells compared to LA or TRAIL alone. Furthermore, combined treatment of LA and TRAIL significantly decreased antiapoptotic proteins such as B-cell lymphoma 2 (Bcl-2), Fas-like inhibitor protein (FLIP), and X-linked inhibitor of apoptosis protein (XIAP), and enhanced the activation of proapoptotic proteins Bid compared to LA or TRAIL alone. In addition, combined treatment of LA and TRAIL upregulated the expression of Death receptor 4 (DR4) and downregulated phosphorylation of nuclear factor κ-light-chain-enhancer of activated B cells (p-NF-κB), inhibitory protein of kB family (p-IκB), and FLIP in A549 and H1299 cells along with disrupted binding of XIAP with caspase3 or NF-κB. Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-κB in TRAIL resistant NSCLCs. MDPI 2018-05-16 /pmc/articles/PMC5983579/ /pubmed/29772677 http://dx.doi.org/10.3390/ijms19051476 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ahn, Deok Soo Lee, Hyo Jung Hwang, Jisung Han, Hyukgyu Kim, Bonglee Shim, BumSang Kim, Sung-Hoon Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title_full | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title_fullStr | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title_full_unstemmed | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title_short | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
title_sort | lambertianic acid sensitizes non-small cell lung cancers to trail-induced apoptosis via inhibition of xiap/nf-κb and activation of caspases and death receptor 4 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983579/ https://www.ncbi.nlm.nih.gov/pubmed/29772677 http://dx.doi.org/10.3390/ijms19051476 |
work_keys_str_mv | AT ahndeoksoo lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT leehyojung lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT hwangjisung lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT hanhyukgyu lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT kimbonglee lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT shimbumsang lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 AT kimsunghoon lambertianicacidsensitizesnonsmallcelllungcancerstotrailinducedapoptosisviainhibitionofxiapnfkbandactivationofcaspasesanddeathreceptor4 |